Kim Forest Enterprise Co., Ltd. (TWSE: 6645)
Health Care · Biotechnology · TW
NT$14.35
+6.30% today · -34.2% 1Y
Kim Forest Enterprise Co., Ltd. (TWSE: 6645) operates in the Biotechnology industry within the Health Care sector. The company is valued at $26.71M and employs 130 people.
Over the last twelve months the share price has lost 34.2%, trading between 11.40 and 26.45.
Tweenvest scores Kim Forest Enterprise Co., Ltd. across four factors: quality 60/100, value 52/100, growth 69/100. Its strongest factor is growth.
6645 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $26.71M
- Revenue (TTM)
- $18.85M
- P/E
- —
- EPS
- -2.24
- Dividend yield
- —
- Beta (5Y)
- -0.05
- 52-week high
- NT$26.45
- 52-week low
- NT$11.40
- Avg volume (3M)
- —
- Shares outstanding
- 60.38M
- Employees
- 130
- Next earnings
- —
About Kim Forest Enterprise Co., Ltd.
Kim Forest Enterprise Co., Ltd. specializes in advanced precision medical products. The company equips healthcare providers with essential diagnostic devices, reagents, and analytical pipelines, enabling crucial screening tests for conditions such as cancer and inherited diseases. Its comprehensive portfolio extends to supporting cancer patients through genetic testing services, personalized drug reports, and monitoring tools. Furthermore, it caters to healthy individuals by offering non-invasive, genome-wide health assessments. Kim Forest also delivers specialized bioinformatics service items, prenatal test kits, and genetically modified models. Notably, its product range also includes SARS-CoV-2 detection kits. Established in 2004, the company is headquartered in New Taipei City, Taiwan.
- ISIN
- TW0006645005
- Founded
- 2004
- Listed since
- Aug 18, 2017
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Chordia Therapeutics Inc.TSE: 190A | $27.40M | ¥56.00 | -1.75% |
| IMB Dx, Inc.KOSDAQ: A461030 | $27.39M | ₩2,605.00 | -8.44% |
| LabGenomics Co., Ltd.KOSDAQ: A084650 | $27.17M | ₩2,440.00 | -12.07% |
| Isofol Medical AB (publ)OM: ISOFOL | $26.73M | Skr0.83 | +3.51% |
| Atossa Therapeutics, Inc.NasdaqCM: ATOS | $25.95M | $2.60 | -4.41% |
| Noile-Immune Biotech Inc.TSE: 4893 | $25.84M | ¥94.00 | -7.84% |
| Seoulin Bioscience Co.,Ltd.KOSDAQ: A038070 | $25.81M | ₩3,810.00 | -6.39% |
| Genesystem Co., Ltd.KOSDAQ: A363250 | $25.76M | ₩4,145.00 | +1.97% |
Figures last refreshed Oct 18, 2026.